TQ Quiz | Updates and Innovations in Macular Degeneration (Mackinac 2023) by Events@optometricedu.com | Aug 17, 2023 | 2023 Mackinac Island, TQ Courses | 0 comments "*" indicates required fields HiddenUpdates and Innovations in Macular DegenerationHiddenDate (Hidden) MM slash DD slash YYYY HiddenEvent Date (Hidden) MM slash DD slash YYYY HiddenEvent 60 days past date (Hidden) MM slash DD slash YYYY HiddenEvent Date Difference (Hidden)1. Patients who have a sibling with AMD have a ______ of developing AMD than those who have a parent with AMD.* A - Higher risk B - Lower risk C - Same risk D - AMD is not related to genetics. 2. All of the following are things that are recommendations for all levels of AMD except:* A - Eat leafy greens B - Don’t smoke C - Drink more water D - Wear sunglass 3. A patient with medium drusen and no AMD pigmentary abnormalities is classified as:* A - Early AMD B - Intermediate AMD C - Severe AMD D - Neovascular AMD 4. A patient with geographic atrophy has ___ 10 year risk of progression for high risk category.* A - 10% B - 35% C - 93% D - 54% 5. What is the current FDA treatment for Geographic Atrophy?* A - Ranibizumab B - Kenalog C - Aflibercept D - Pegcetacoplan 6. What percentage of patients with AMD will develop neovascular AMD:* A - 10-20% B - 30-40% C - 50-60% D - 70-80% 7. Which of the following is the most appropriate testing to monitor for conversion to wet AMD:* A - Visual acuity B - OCT C - Visual field D - Fundus photos 8. Patients with geographic atrophy* A - Don’t need to be referred to a Retina specialist for treatment. B - Do need to be referred to a Retina specialist for treatment. C - Do need to be referred to a general Ophthalmologist for treatment. D - Do need to be referred to an Optometrist for treatment. 9. Which component of the original AREDS formula vitamin was removed in the AREDS 2 formula.* A - Vitamin A B - Vitamin K C - Vitamin C D - Vitamin D 10. The AREDS 2 ten year follow up study showed* A - Consistent results to previous studies in AMD patients using the vitamins. B - There was not a 10 year follow up of AREDS 2. C - That AREDS 2 vitamins were helpful for early AMD patients. D - Inconsistent results to previous studies in AMD patients using the vitamins 11. Vitamins and supplements* A - Are monitored by the FDA to make sure they contain what is on the label. B - Are not monitored by the FDA to make sure they contain what is on the label C - Are monitored by the GMP to make sure they contain what is on the label D - Are monitored by the GMO to make sure they contain what is on the label 12. All the following digital retina home monitoring tools are phone based except which:* A - OdySight Care B - ForseeHome C - Home Vision Monitor D - Alleye 13. Per AOA treatment guidelines often should patients with early AMD without neovascularization be seen:* A - When patients note changes B - 3 years C - 6 months D - 1 year 14. There is currently FDA approved treatment which of the following:* A - Neovascular AMD only B - Mild AMD without neovascularization C - Moderate AMD without neovascularization D - Both Geographic atrophy and neovascular AMD 15. The current number one treatment for neovascular AMD is:* A - Steroids B - NSAIDS C - Anti-VEGF D - Laser photocoagulation 16. Faricimab is dual mechanism treatment for neovascular AMD working as anti-VEGF and ____.* A - Anti-Ang-2 B - Anti-Prolactin C - Nothing it only has one mechanism D - None of the above 17. What is the most appropriate timeline for Retina specialist referral for a new diagnosis of neovascular AMD?* A - 1 hour B - 1 week C - 6 months D - 1 year 18. Which of the following types of treatments are currently in FDA trials for AMD:* A - Gene therapy B - Biosimilars C - Devices D - All of the above 19. Patients with permanent or pending permanent vision loss would benefit from all of the following except:* A - Best corrected SRx B - Low vision consult C - Sunglasses D - Evaluation with center for the blind 20. Links have been indicated between AMD and all of the following neurodegenerative diseases except:* A - Alzheimer’s B - Parkinson C - Multiple Sclerosis D - POTS Personal InformationName* First Last Email* Phone*OE Tracker # License # Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationPromotional Code Updates and Innovations in Macular Degeneration | TQ Credit*After 10/18/2023, pricing will increase to $30. Price: (Past 60 Days) Updates and Innovations in Macular Degeneration | TQ CreditThis course was presented over 60 days ago. Due to this late submission of TQ, your TQ credit price is $30. Price: Retake Discount Price: Promotional Discount Price: (Past 60 Days) Retake Discount Price: (Past 60 Days) Promotional Discount Price: Paying Via Credit Card A Paypal account is not required to pay using the button below. To pay using a credit card, click the Paypal button below. A new window will appear and a button "Pay with Debit or Credit Card" is available at the bottom of that window for your convenience. Payment MethodPayPal CheckoutCredit Card American ExpressDiscoverMasterCardVisaSupported Credit Cards: American Express, Discover, MasterCard, Visa Card Number Card Number Expiration Date Expiration Date Security Code Security Code Cardholder Name HiddenCourse Information (HIDDEN)HiddenCourse Name (HIDDEN) HiddenRetake Code (HIDDEN) HiddenQuiz URL (HIDDEN)Do not include ending backslash (aka no .com/) HiddenCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
